CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.
about
The role of CD44 in epithelial-mesenchymal transition and cancer developmentManagement of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalThe associations between immunity-related genes and breast cancer prognosis in Korean women.CD44 increases the efficiency of distant metastasis of breast cancerEnrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosisCD44-mediated activation of α5β1-integrin, cortactin and paxillin signaling underpins adhesion of basal-like breast cancer cells to endothelium and fibronectin-enriched matrices.CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma.Intratumor heterogeneity predicts metastasis of triple-negative breast cancer.Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.Axillary Skip Metastases and the False-Negative Rate of Sentinel Lymph Node Biopsy in Patients With Breast Cancer Are Related to Negative ALDH-1 Expression and Ki-67 Expression.Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.
P2860
Q26771509-CA2FC69A-292D-4808-9AB5-F1C7D266733FQ26853543-22C802EA-0ADB-4F98-A1B5-059FB55D8669Q33975510-D4BB4247-9888-476E-84A4-CCE333E4218DQ35793831-E5D979C2-AD7B-4F37-80D1-D22116DD6E31Q36504123-322A15FC-DA36-487A-97BB-8E0609EF62A0Q36546783-902DE625-7919-4C44-9F81-1B099F1202C6Q42502215-95B6521D-0DF6-4E1D-9F30-A67815E71903Q47142272-344F88B0-B5C8-4B0B-94A9-143031047CB6Q47801879-7CBBAC67-23D5-4ADA-8C9C-097E8E947E24Q48832407-CBEE79EC-C9B5-4760-A074-70C60D5C6B29Q54208413-8E94731B-964F-4832-8512-31C695C52FEBQ55070669-5E8B49C5-F22A-4BD0-ABAD-4324C786B1D0
P2860
CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
CD44 is prognostic for overall ...... vation with 25 year follow-up.
@en
CD44 is prognostic for overall ...... vation with 25 year follow-up.
@nl
type
label
CD44 is prognostic for overall ...... vation with 25 year follow-up.
@en
CD44 is prognostic for overall ...... vation with 25 year follow-up.
@nl
prefLabel
CD44 is prognostic for overall ...... vation with 25 year follow-up.
@en
CD44 is prognostic for overall ...... vation with 25 year follow-up.
@nl
P2093
P2860
P1476
CD44 is prognostic for overall ...... vation with 25 year follow-up.
@en
P2093
J B Mitchell
K Camphausen
M E Lippman
N L Simone
P2860
P2888
P356
10.1007/S10549-013-2758-9
P407
P577
2013-11-26T00:00:00Z
P6179
1008730463